Molecular Imaging: Page 278

SNMMI builds global ties with China partnership

By Wayne Forrest

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Chinese Society of Nuclear Medicine may be worlds apart on a map, but when it comes to priorities and advancing the specialty, the two organizations have much in common.

February 11, 2013

SUVmax shows survival for NSCLC patients

By AuntMinnie.com staff writers

Maximum standardized uptake value (SUVmax) may be a significant and clinically independent marker to indicate progression-free survival in stage I non-small cell lung cancer (NSCLC) patients treated with stereotactic body radiation therapy, according to a study presented at the Cancer Imaging and Radiation Therapy Symposium.

February 7, 2013

AuntMinnie.com Molecular Imaging Insider

By Wayne Forrest

February 7, 2013

FDA issues Alzheimer's treatment guidelines

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration on February 7 issued a proposal designed to assist companies that are developing new treatments for patients in the early stages of Alzheimer's disease, before the onset of overt dementia.

February 6, 2013

Study shows PiB-PET detects amyloid plaque in heart

By Wayne Forrest

Swedish researchers are expanding the use of PET imaging with carbon-11-labeled Pittsburgh Compound B (PiB) to cardiac amyloidosis, confirming the biomarker's ability to detect amyloid plaque deposits in the heart in a first-of-its-kind study in the February issue of the Journal of Nuclear Medicine.

February 4, 2013

Navidea announces U.S. clinical trial partner

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has entered into an agreement with Maimonides Medical Center in New York City to investigate the utility of its Lymphoseek product in lymphatic mapping procedures for colorectal cancer.

February 3, 2013

MITA backs coverage for beta-amyloid PET

By AuntMinnie.com staff writers

The Medical Imaging and Technology Alliance (MITA) is encouraging the U.S. Centers for Medicare and Medicaid Services to consider diagnostic end points as the basis for its coverage of beta-amyloid imaging.

January 31, 2013

Digirad nets additional FDA clearance for ergo

By AuntMinnie.com staff writers

Nuclear medicine firm Digirad has received U.S. Food and Drug Administration 510(k) clearance for new applications on its ergo imaging general-purpose nuclear medicine camera.

January 31, 2013

Nordion posts net loss, mulls over strategic options

By AuntMinnie.com staff writers

In the wake of a difficult fiscal 2012, Nordion has hired advisors to explore strategic alternatives.

January 30, 2013

More from Arab Health; CMS panel weighs amyloid PET; Medical Imaging Confidence Index

By Erik L. Ridley

January 30, 2013

CMS committee not yet swayed on brain amyloid PET imaging

By Wayne Forrest

A U.S. Centers for Medicare and Medicaid Services (CMS) advisory committee said on Wednesday that more studies are needed to confirm the efficacy of Eli Lilly and Avid Radiopharmaceuticals' Amyvid radiopharmaceutical for brain beta-amyloid PET imaging.

January 30, 2013

PET/CT predicts response to endorectal radiotherapy

By Eric Barnes

PET/CT results can predict which patients will respond to high-dose-rate endorectal brachytherapy for stage II and III rectal cancer, according to a study presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The results could pave the way for easier treatments and better outcomes.

January 29, 2013

Previous Page

Page 278 of 615

Next Page